Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Faisability and Efficacity of the Reinforced Communautary Support Program (PARC) on the Complications of Chemsex

NCT06610916 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT06610916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06610916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Faisability and Efficacity of the Reinforced Communautary Support Program (PARC) on the Complications of Chemsex
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 20, 2024
Completion date
September 20, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, chemsex, infections, sexual disorder, physiological